Cortechs.ai
Cortechs.ai provides AI-powered quantitative imaging tools that help clinicians diagnose and monitor neurological and oncological diseases. The company sells NeuroQuant® and related software as FDA 510(k)-cleared, CE-marked medical-device applications delivered via SaaS or licensing to radiologists, neurologists, oncologists, and medical institutions. Its platform uses machine learning and medical imaging algorithms for automated brain segmentation, volumetric analysis, and lesion quantification to assess atrophy, tumors, MS lesions and ARIA. The products integrate with clinical workflows and PACS, and the suite also includes NeuroAlign CT and OnQ Prostate for CT and oncology use. Cortechs.ai is deployed at over 1,400 institutions across 44 countries with more than 2,000,000 brains processed, supporting clinical care and research scale.
Cortechs.ai
Cortechs.ai provides AI-powered quantitative imaging tools that help clinicians diagnose and monitor neurological and oncological diseases. The company sells NeuroQuant® and related software as FDA 510(k)-cleared, CE-marked medical-device applications delivered via SaaS or licensing to radiologists, neurologists, oncologists, and medical institutions. Its platform uses machine learning and medical imaging algorithms for automated brain segmentation, volumetric analysis, and lesion quantification to assess atrophy, tumors, MS lesions and ARIA. The products integrate with clinical workflows and PACS, and the suite also includes NeuroAlign CT and OnQ Prostate for CT and oncology use. Cortechs.ai is deployed at over 1,400 institutions across 44 countries with more than 2,000,000 brains processed, supporting clinical care and research scale.
